These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 8626455)
1. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. Shaul PW; Smart EJ; Robinson LJ; German Z; Yuhanna IS; Ying Y; Anderson RG; Michel T J Biol Chem; 1996 Mar; 271(11):6518-22. PubMed ID: 8626455 [TBL] [Abstract][Full Text] [Related]
2. Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions. Feron O; Michel JB; Sase K; Michel T Biochemistry; 1998 Jan; 37(1):193-200. PubMed ID: 9425039 [TBL] [Abstract][Full Text] [Related]
3. A chimeric transmembrane domain directs endothelial nitric-oxide synthase palmitoylation and targeting to plasmalemmal caveolae. Prabhakar P; Cheng V; Michel T J Biol Chem; 2000 Jun; 275(25):19416-21. PubMed ID: 10787410 [TBL] [Abstract][Full Text] [Related]
4. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Liu J; García-Cardeña G; Sessa WC Biochemistry; 1996 Oct; 35(41):13277-81. PubMed ID: 8873592 [TBL] [Abstract][Full Text] [Related]
5. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae. Peterson TE; Poppa V; Ueba H; Wu A; Yan C; Berk BC Circ Res; 1999 Jul; 85(1):29-37. PubMed ID: 10400908 [TBL] [Abstract][Full Text] [Related]
6. Targeting and translocation of endothelial nitric oxide synthase. Michel T Braz J Med Biol Res; 1999 Nov; 32(11):1361-6. PubMed ID: 10559837 [TBL] [Abstract][Full Text] [Related]
7. Targeting of a G alpha subunit (Gi1 alpha) and c-Src tyrosine kinase to caveolae membranes: clarifying the role of N-myristoylation. Song KS; Sargiacomo M; Galbiati F; Parenti M; Lisanti MP Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):293-303. PubMed ID: 9193783 [TBL] [Abstract][Full Text] [Related]
8. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. García-Cardeña G; Oh P; Liu J; Schnitzer JE; Sessa WC Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6448-53. PubMed ID: 8692835 [TBL] [Abstract][Full Text] [Related]
9. Depalmitoylation of endothelial nitric-oxide synthase by acyl-protein thioesterase 1 is potentiated by Ca(2+)-calmodulin. Yeh DC; Duncan JA; Yamashita S; Michel T J Biol Chem; 1999 Nov; 274(46):33148-54. PubMed ID: 10551886 [TBL] [Abstract][Full Text] [Related]
10. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. Feron O; Belhassen L; Kobzik L; Smith TW; Kelly RA; Michel T J Biol Chem; 1996 Sep; 271(37):22810-4. PubMed ID: 8798458 [TBL] [Abstract][Full Text] [Related]
11. Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction. Igarashi J; Michel T J Biol Chem; 2000 Oct; 275(41):32363-70. PubMed ID: 10921915 [TBL] [Abstract][Full Text] [Related]
12. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. Michel JB; Feron O; Sase K; Prabhakar P; Michel T J Biol Chem; 1997 Oct; 272(41):25907-12. PubMed ID: 9325323 [TBL] [Abstract][Full Text] [Related]
13. The endothelial nitric-oxide synthase-caveolin regulatory cycle. Feron O; Saldana F; Michel JB; Michel T J Biol Chem; 1998 Feb; 273(6):3125-8. PubMed ID: 9452418 [TBL] [Abstract][Full Text] [Related]